Florida Senate - 2026 SENATOR AMENDMENT
Bill No. CS/HB 733, 1st Eng.
Ì476906AÎ476906
LEGISLATIVE ACTION
Senate . House
.
.
.
Floor: 1/RE/2R .
03/12/2026 05:45 PM .
—————————————————————————————————————————————————————————————————
—————————————————————————————————————————————————————————————————
Senator Garcia moved the following:
1 Senate Amendment (with title amendment)
2
3 Delete everything after the enacting clause
4 and insert:
5 Section 1. Paragraph (a) of subsection (1) and subsection
6 (5) of section 381.4019, Florida Statutes, are amended to read:
7 381.4019 Dental Student Loan Repayment Program.—The Dental
8 Student Loan Repayment Program is established to support the
9 state Medicaid program and promote access to dental care by
10 supporting qualified dentists and dental hygienists who treat
11 medically underserved populations in dental health professional
12 shortage areas or medically underserved areas.
13 (1) As used in this section, the term:
14 (a) “Dental health professional shortage area” means a
15 geographic area, an area with a special population, or a
16 facility designated as such by the Health Resources and Services
17 Administration of the United States Department of Health and
18 Human Services.
19 (5) A Florida-licensed dentist, Florida-licensed dental
20 hygienist, dental student, or dental hygiene student who
21 demonstrates an offer of employment in a public health program
22 or private practice as specified in paragraph (2)(a) may apply
23 for the loan program before obtaining active employment but may
24 not be awarded funds from the loan program until he or she meets
25 the requirements of subsection (2).
26 Section 2. Paragraph (f) of subsection (1), paragraphs (a)
27 and (c) of subsection (3), paragraph (h) of subsection (4),
28 paragraph (a) of subsection (8), and subsection (11) of section
29 381.986, Florida Statutes, are amended, to read:
30 381.986 Medical use of marijuana.—
31 (1) DEFINITIONS.—As used in this section, the term:
32 (f) “Low-THC cannabis” means a plant of the genus Cannabis,
33 whether growing or not the dried flowers of which contain 0.8
34 percent or less of tetrahydrocannabinol and more than 10 percent
35 of cannabidiol weight for weight; the seeds thereof; the resin
36 extracted from any part of such plant; and every or any
37 compound, manufacture, salt, derivative, mixture, or preparation
38 of such plant or its seeds or resin, excluding edibles; which
39 contains 0.8 percent or less of tetrahydrocannabinol and more
40 than 2 percent of cannabidiol, weight for weight, which that is
41 dispensed from a medical marijuana treatment center.
42 (3) QUALIFIED PHYSICIANS AND MEDICAL DIRECTORS.—
43 (a) Before being approved as a qualified physician and
44 before each license renewal, a physician must successfully
45 complete a 2-hour course and subsequent examination offered by
46 the Florida Medical Association or the Florida Osteopathic
47 Medical Association which encompass the requirements of this
48 section and any rules adopted hereunder. Qualified physicians
49 must renew the course certification biennially. The course and
50 examination must be administered at least annually and may be
51 offered in a distance learning format, including an electronic,
52 online format that is available upon request. The price of the
53 course may not exceed $500.
54 (c) Before being employed as a medical director and before
55 each license renewal, a medical director must successfully
56 complete a 2-hour course and subsequent examination offered by
57 the Florida Medical Association or the Florida Osteopathic
58 Medical Association which encompass the requirements of this
59 section and any rules adopted hereunder. Medical directors must
60 renew the course certification biennially. The course and
61 examination must be administered at least annually and may be
62 offered in a distance learning format, including an electronic,
63 online format that is available upon request. The price of the
64 course may not exceed $500.
65 (4) PHYSICIAN CERTIFICATION.—
66 (h) An active order for low-THC cannabis or medical
67 cannabis issued pursuant to former s. 381.986, Florida Statutes
68 2016, and registered with the compassionate use registry before
69 June 23, 2017, is deemed a physician certification, and all
70 patients possessing such orders are deemed qualified patients
71 until the department begins issuing medical marijuana use
72 registry identification cards.
73 (8) MEDICAL MARIJUANA TREATMENT CENTERS.—
74 (a) The department shall license medical marijuana
75 treatment centers to ensure reasonable statewide accessibility
76 and availability as necessary for qualified patients registered
77 in the medical marijuana use registry and who are issued a
78 physician certification under this section.
79 1. As soon as practicable, but no later than July 3, 2017,
80 the department shall license as a medical marijuana treatment
81 center any entity that holds an active, unrestricted license to
82 cultivate, process, transport, and dispense low-THC cannabis,
83 medical cannabis, and cannabis delivery devices, under former s.
84 381.986, Florida Statutes 2016, before July 1, 2017, and which
85 meets the requirements of this section. In addition to the
86 authority granted under this section, these entities are
87 authorized to dispense low-THC cannabis, medical cannabis, and
88 cannabis delivery devices ordered pursuant to former s. 381.986,
89 Florida Statutes 2016, which were entered into the compassionate
90 use registry before July 1, 2017, and are authorized to begin
91 dispensing marijuana under this section on July 3, 2017. The
92 department may grant variances from the representations made in
93 such an entity’s original application for approval under former
94 s. 381.986, Florida Statutes 2014, pursuant to paragraph (e).
95 2. The department shall license as medical marijuana
96 treatment centers 10 applicants that meet the requirements of
97 this section, under the following parameters:
98 a. As soon as practicable, but no later than August 1,
99 2017, the department shall license any applicant whose
100 application was reviewed, evaluated, and scored by the
101 department and which was denied a dispensing organization
102 license by the department under former s. 381.986, Florida
103 Statutes 2014; which had one or more administrative or judicial
104 challenges pending as of January 1, 2017, or had a final ranking
105 within one point of the highest final ranking in its region
106 under former s. 381.986, Florida Statutes 2014; which meets the
107 requirements of this section; and which provides documentation
108 to the department that it has the existing infrastructure and
109 technical and technological ability to begin cultivating
110 marijuana within 30 days after registration as a medical
111 marijuana treatment center.
112 b. As soon as practicable, the department shall license one
113 applicant that is a recognized class member of Pigford v.
114 Glickman, 185 F.R.D. 82 (D.D.C. 1999), or In Re Black Farmers
115 Litig., 856 F. Supp. 2d 1 (D.D.C. 2011). An applicant licensed
116 under this sub-subparagraph is exempt from the requirement of
117 subparagraph (b)2. An applicant that applies for licensure under
118 this sub-subparagraph, pays its initial application fee, is
119 determined by the department through the application process to
120 qualify as a recognized class member, and is not awarded a
121 license under this sub-subparagraph may transfer its initial
122 application fee to one subsequent opportunity to apply for
123 licensure under subparagraph 4.
124 c. As soon as practicable, but no later than October 3,
125 2017, the department shall license applicants that meet the
126 requirements of this section in sufficient numbers to result in
127 10 total licenses issued under this subparagraph, while
128 accounting for the number of licenses issued under sub
129 subparagraphs a. and b.
130 3. For up to two of the licenses issued under subparagraph
131 2., the department shall give preference to applicants that
132 demonstrate in their applications that they own one or more
133 facilities that are, or were, used for the canning,
134 concentrating, or otherwise processing of citrus fruit or citrus
135 molasses and will use or convert the facility or facilities for
136 the processing of marijuana.
137 4. Within 6 months after the registration of 100,000 active
138 qualified patients in the medical marijuana use registry, the
139 department shall license four additional medical marijuana
140 treatment centers that meet the requirements of this section.
141 Thereafter, the department shall license four medical marijuana
142 treatment centers within 6 months after the registration of each
143 additional 100,000 active qualified patients in the medical
144 marijuana use registry that meet the requirements of this
145 section.
146 (11) PREEMPTION.—Regulation of cultivation, processing, and
147 delivery of marijuana by medical marijuana treatment centers is
148 preempted to the state except as provided in this subsection.
149 (a) As used in this subsection, the term “park” means any
150 public or private property, excluding private residences, which
151 has equipment specifically installed for children’s athletic,
152 recreational, or leisure activities, including, but not limited
153 to, playgrounds and athletic playing fields. The term does not
154 include conservation and recreation lands acquired in accordance
155 with chapter 259 or conservation and recreation lands designated
156 by a local government, unless such lands contain equipment
157 installed for children’s athletic, recreational, or leisure
158 activities.
159 (b)(a) A medical marijuana treatment center cultivating or
160 processing facility may not be located within 500 feet of the
161 real property that comprises a park, a child care facility as
162 defined in s. 402.302, a facility that provides early learning
163 services as specified in s. 1000.04(1), or a public or private
164 elementary school, middle school, or secondary school. The
165 subsequent establishment of any such park, child care facility,
166 early learning facility, or school after the approval of the
167 medical marijuana treatment center cultivating or processing
168 facility does not affect the continued operation or location of
169 the approved cultivating or processing facility. A medical
170 marijuana treatment center cultivating or processing facility
171 that was approved by the department before July 1, 2026, is
172 exempt from the distance restrictions relating to parks, child
173 care facilities, and early learning facilities.
174 (c)1.(b)1. A county or municipality may, by ordinance, ban
175 medical marijuana treatment center dispensing facilities from
176 being located within the boundaries of that county or
177 municipality. A county or municipality that does not ban
178 dispensing facilities under this subparagraph may not place
179 specific limits, by ordinance, on the number of dispensing
180 facilities that may locate within that county or municipality.
181 2. A municipality may determine by ordinance the criteria
182 for the location of, and other permitting requirements that do
183 not conflict with state law or department rule for, medical
184 marijuana treatment center dispensing facilities located within
185 the boundaries of that municipality. A county may determine by
186 ordinance the criteria for the location of, and other permitting
187 requirements that do not conflict with state law or department
188 rule for, all such dispensing facilities located within the
189 unincorporated areas of that county. Except as provided in
190 paragraph (d) (c), a county or municipality may not enact
191 ordinances for permitting or for determining the location of
192 dispensing facilities which are more restrictive than its
193 ordinances permitting or determining the locations for
194 pharmacies licensed under chapter 465. A municipality or county
195 may not charge a medical marijuana treatment center a license or
196 permit fee in an amount greater than the fee charged by such
197 municipality or county to pharmacies. A dispensing facility
198 location approved by a municipality or county pursuant to former
199 s. 381.986(8)(b), Florida Statutes 2016, is not subject to the
200 location requirements of this subsection.
201 (d)(c) A medical marijuana treatment center dispensing
202 facility may not be located within 500 feet of the real property
203 that comprises a park, a child care facility as defined in s.
204 402.302, a facility that provides early learning services as
205 specified in s. 1000.04(1), or a public or private elementary
206 school, middle school, or secondary school unless the county or
207 municipality approves the location through a formal proceeding
208 open to the public at which the county or municipality
209 determines that the location promotes the public health, safety,
210 and general welfare of the community. The subsequent
211 establishment of any such park, child care facility, early
212 learning facility, or school after the approval of the medical
213 marijuana treatment center dispensing facility does not affect
214 the continued operation or location of the approved dispensing
215 facility. A medical marijuana treatment center dispensing
216 facility that was approved by the department before July 1,
217 2026, is exempt from the distance restrictions relating to
218 parks, child care facilities, and early learning facilities.
219 (e)(d) This subsection does not prohibit any local
220 jurisdiction from ensuring medical marijuana treatment center
221 facilities comply with the Florida Building Code, the Florida
222 Fire Prevention Code, or any local amendments to the Florida
223 Building Code or the Florida Fire Prevention Code.
224 Section 3. Section 381.994, Florida Statutes, is created to
225 read:
226 381.994 Neurofibromatosis Disease Grant Program.—
227 (1)(a) There is created within the Department of Health the
228 Neurofibromatosis Disease Grant Program. The purpose of the
229 program is to advance the progress of research and cures for
230 neurofibromatosis by awarding grants through a competitive,
231 peer-reviewed process.
232 (b) Subject to legislative appropriation, the program shall
233 award grants for scientific and clinical research to further the
234 search for new diagnostics, treatments, and cures for
235 neurofibromatosis.
236 (2)(a) Applications for grants for neurofibromatosis
237 disease research may be submitted by any university or
238 established research institute in this state. All qualified
239 investigators in this state, regardless of institutional
240 affiliation, shall have equal access and opportunity to compete
241 for the research funding. Preference may be given to grant
242 proposals that foster collaboration among institutions,
243 researchers, and community practitioners, as such proposals
244 support the advancement of treatments and cures of
245 neurofibromatosis through basic or applied research. Grants
246 shall be awarded by the department, after consultation with the
247 Rare Disease Advisory Council under s. 381.99, on the basis of
248 scientific merit, as determined by the competitive, peer
249 reviewed process to ensure objectivity, consistency, and high
250 quality. The following types of applications may be considered
251 for funding:
252 1. Investigator-initiated research grants.
253 2. Institutional research grants.
254 3. Collaborative research grants, including those that
255 advance the finding of treatments and cures through basic or
256 applied research.
257 (b) To ensure appropriate and fair evaluation of grant
258 applications based on scientific merit, the department shall
259 appoint peer review panels of independent, scientifically
260 qualified individuals to review the scientific merit of each
261 proposal and establish its priority score. The priority scores
262 must be forwarded to the council, and the council shall consider
263 priority scores in determining which proposals are recommended
264 for funding.
265 (3) For purposes of performing their duties under this
266 section, the Rare Disease Advisory Council and the peer review
267 panels shall establish and follow rigorous guidelines for
268 ethical conduct and adhere to a strict policy with regard to
269 conflicts of interest. A member of the council or panel may not
270 participate in any discussion or decision of the council or
271 panel with respect to a research proposal by any firm, entity,
272 or agency with which the member is associated as a member of the
273 governing body or as an employee or with which the member has
274 entered into a contractual arrangement.
275 (4) Notwithstanding s. 216.301 and pursuant to s. 216.351,
276 the balance of any appropriation from the General Revenue Fund
277 for the Neurofibromatosis Disease Grant Program which is not
278 disbursed but is obligated pursuant to contract or committed to
279 be expended by June 30 of the fiscal year in which the funds are
280 appropriated may be carried forward for up to 5 years after the
281 effective date of the original appropriation.
282 Section 4. Paragraph (i) is added to subsection (3) of
283 section 383.14, Florida Statutes, to read:
284 383.14 Screening for metabolic disorders, other hereditary
285 and congenital disorders, and environmental risk factors.—
286 (3) DEPARTMENT OF HEALTH; POWERS AND DUTIES.—The department
287 shall administer and provide certain services to implement the
288 provisions of this section and shall:
289 (i) Create an evidence-based educational pamphlet on the
290 nutritional needs of preterm infants to be provided to parents
291 and guardians of infants receiving care in a neonatal intensive
292 care unit. By January 1, 2027, the department shall make the
293 pamphlet available electronically to hospitals licensed under
294 chapter 395 to provide neonatal intensive care services. The
295 pamphlet must include, but need not be limited to, information
296 on preterm infants relating to all of the following:
297 1. The specific nutritional needs of preterm infants;
298 2. The health risks associated with nutritional deficits
299 and the potential need for nutritional supplementation;
300 3. Different nutritional sources for infants, including
301 maternal breast milk, pasteurized human donor milk, infant
302 formula, human-milk-derived fortifiers, and bovine-milk-derived
303 fortifiers, and the recommended uses for each type of
304 nutritional source;
305 4. The importance of maternal breast milk for meeting the
306 nutritional and developmental needs of infants, and the
307 alternative of pasteurized human donor milk if maternal breast
308 milk is not available;
309 5. The importance of having a physician discuss with family
310 members the risks and benefits of all nutritional sources
311 available, based on the preterm infant’s individual situation;
312 and
313 6. Necrotizing enterocolitis, the risk factors for
314 necrotizing enterocolitis, and the potential for a human-milk
315 based diet, including maternal and pasteurized donor breast
316 milk, to reduce the risk of necrotizing enterocolitis.
317
318 All provisions of this subsection must be coordinated with the
319 provisions and plans established under this chapter, chapter
320 411, and Pub. L. No. 99-457.
321 Section 5. Present paragraph (g) of subsection (16) of
322 section 395.4025, Florida Statutes, is redesignated as paragraph
323 (h), and a new paragraph (g) is added to subsection (16) of that
324 section, to read:
325 395.4025 Trauma centers; selection; quality assurance;
326 records.—
327 (16)
328 (g) Notwithstanding the statutory capacity limits
329 established in subsection (8), s. 395.402(1), or any other
330 provision of this part, a specialty licensed children’s hospital
331 licensed by the agency which has maintained its specialty
332 license as a children’s hospital for at least 5 years must be
333 deemed to be in compliance with trauma center standards and be
334 designated by the department as a Level I or Level II pediatric
335 trauma center, as applicable and pursuant to subsection (7), if
336 the hospital demonstrates to the department that it holds a
337 valid certificate of trauma center verification by the American
338 College of Surgeons.
339 Section 6. Present paragraphs (d) through (hh) of
340 subsection (5) of section 456.074, Florida Statutes, are
341 redesignated as paragraphs (e) through (ii), respectively, and a
342 new paragraph (d) is added to that subsection, to read:
343 456.074 Certain health care practitioners; immediate
344 suspension of license.—
345 (5) The department shall issue an emergency order
346 suspending the license of any health care practitioner who is
347 arrested for committing or attempting, soliciting, or conspiring
348 to commit any act that would constitute a violation of any of
349 the following criminal offenses in this state or similar
350 offenses in another jurisdiction:
351 (d) Section 782.04, relating to murder.
352 Section 7. Paragraph (c) of subsection (2) of section
353 464.0156, Florida Statutes, is amended to read:
354 464.0156 Delegation of duties.—
355 (2)
356 (c) A registered nurse may not delegate the administration
357 of any controlled substance listed in Schedule II, Schedule III,
358 or Schedule IV of s. 893.03 or 21 U.S.C. s. 812, except that a
359 registered nurse may delegate:
360 1. For The administration of an insulin syringe that is
361 prefilled with the proper dosage by a pharmacist or an insulin
362 pen that is prefilled by the manufacturer; and
363 2. To a home health aide for medically fragile children as
364 defined in s. 400.462(18), the administration of a Schedule IV
365 controlled substance prescribed for the emergency treatment of
366 an active seizure.
367 Section 8. Paragraph (c) of subsection (3) of section
368 491.005, Florida Statutes, is amended to read:
369 491.005 Licensure by examination.—
370 (3) MARRIAGE AND FAMILY THERAPY.—Upon verification of
371 documentation and payment of a fee not to exceed $200, as set by
372 board rule, the department shall issue a license as a marriage
373 and family therapist to an applicant whom the board certifies
374 has met all of the following criteria:
375 (c)1. Attained one of the following:
376 a. A minimum of a master’s degree in marriage and family
377 therapy from a program accredited by the Commission on
378 Accreditation for Marriage and Family Therapy Education.
379 b. A minimum of a master’s degree with a major emphasis in
380 marriage and family therapy or a closely related field from a
381 university program accredited by the Council on Accreditation of
382 Counseling and Related Educational Programs and graduate courses
383 approved by the board.
384 c. A minimum of a master’s degree with an emphasis in
385 marriage and family therapy or a closely related field, with a
386 degree conferred before September 1, 2032 2027, from an
387 institutionally accredited college or university and graduate
388 courses approved by the board.
389 2. If the course title that appears on the applicant’s
390 transcript does not clearly identify the content of the
391 coursework, the applicant provided additional documentation,
392 including, but not limited to, a syllabus or catalog description
393 published for the course. The required master’s degree must have
394 been received in an institution of higher education that, at the
395 time the applicant graduated, was fully accredited by an
396 institutional accrediting body recognized by the Council for
397 Higher Education Accreditation or its successor organization or
398 was a member in good standing with Universities Canada, or an
399 institution of higher education located outside the United
400 States and Canada which, at the time the applicant was enrolled
401 and at the time the applicant graduated, maintained a standard
402 of training substantially equivalent to the standards of
403 training of those institutions in the United States which are
404 accredited by an institutional accrediting body recognized by
405 the Council for Higher Education Accreditation or its successor
406 organization. Such foreign education and training must have been
407 received in an institution or program of higher education
408 officially recognized by the government of the country in which
409 it is located as an institution or program to train students to
410 practice as professional marriage and family therapists or
411 psychotherapists. The applicant has the burden of establishing
412 that the requirements of this provision have been met, and the
413 board shall require documentation, such as an evaluation by a
414 foreign equivalency determination service, as evidence that the
415 applicant’s graduate degree program and education were
416 equivalent to an accredited program in this country. An
417 applicant with a master’s degree from a program that did not
418 emphasize marriage and family therapy may complete the
419 coursework requirement in a training institution fully
420 accredited by the Commission on Accreditation for Marriage and
421 Family Therapy Education recognized by the United States
422 Department of Education.
423
424 For the purposes of dual licensure, the department shall license
425 as a marriage and family therapist any person who meets the
426 requirements of s. 491.0057. Fees for dual licensure may not
427 exceed those stated in this subsection.
428 Section 9. Paragraph (f) of subsection (1) of section
429 1004.551, Florida Statutes, is amended to read:
430 1004.551 University of Florida Center for Autism and
431 Neurodevelopment.—There is created at the University of Florida
432 the Center for Autism and Neurodevelopment.
433 (1) The center shall:
434 (f) Develop an autism micro-credential to provide
435 specialized training in supporting students with autism.
436 1. The micro-credential must be stackable with the autism
437 endorsement and be available to:
438 a. Instructional personnel as defined in s. 1012.01(2);
439 b. Prekindergarten instructors as specified in ss. 1002.55,
440 1002.61, and 1002.63; and
441 c. Child care personnel as defined in ss. 402.302(3) and
442 1002.88(1)(e); and
443 d. Early intervention service providers credentialed
444 through the Early Steps Program.
445 2. The micro-credential must require participants to
446 demonstrate competency in:
447 a. Identifying behaviors associated with autism.
448 b. Supporting the learning environment in both general and
449 specialized classroom settings.
450 c. Promoting the use of assistive technologies.
451 d. Applying evidence-based instructional practices.
452 3. The micro-credential must:
453 a. Be provided at no cost to eligible participants.
454 b. Be competency-based, allowing participants to complete
455 the credentialing process either in person or online.
456 c. Permit participants to receive the micro-credential at
457 any time during training once competency is demonstrated.
458 4. Individuals eligible under subparagraph 1. who complete
459 the micro-credential are eligible for a one-time stipend, as
460 determined in the General Appropriations Act. The center shall
461 administer stipends for the micro-credential.
462 Section 10. This act shall take effect July 1, 2026.
463
464 ================= T I T L E A M E N D M E N T ================
465 And the title is amended as follows:
466 Delete everything before the enacting clause
467 and insert:
468 A bill to be entitled
469 An act relating to the Department of Health; amending
470 s. 381.4019, F.S.; revising the definition of the term
471 “dental health professional shortage area”; revising
472 eligibility requirements for dentists and dental
473 hygienists participating in the Dental Student Loan
474 Repayment Program; amending s. 381.986, F.S.; revising
475 the definition of the term “low-THC cannabis”;
476 revising requirements for department approval of
477 qualified physicians and medical directors of medical
478 marijuana treatment centers; deleting obsolete
479 language; defining the term “park”; prohibiting
480 medical marijuana treatment centers’ cultivating,
481 processing, or dispensing facilities from being
482 located within a specified distance of parks, child
483 care facilities, or facilities providing early
484 learning services; authorizing counties and
485 municipalities to approve a dispensing facility within
486 such distance under certain circumstances; providing
487 that the subsequent establishment of any park, child
488 care facility, early learning facility, or school
489 after the approval of a medical marijuana treatment
490 center’s cultivating, processing, or dispensing
491 facility does not affect the continued operation or
492 location of the approved cultivating, processing, or
493 dispensing facility; exempting cultivating,
494 processing, or dispensing facilities approved before a
495 specified date from such distance requirements;
496 creating s. 381.994, F.S.; creating the
497 Neurofibromatosis Disease Grant Program within the
498 department; providing the purpose of the program;
499 requiring the program, subject to legislative
500 appropriation, to award grants for certain purposes;
501 specifying entities that are eligible to apply for
502 grants under the program; allowing certain grant
503 proposals to receive preference in the awarding of
504 grants; requiring the department to award grants after
505 consulting with the Rare Disease Advisory Council;
506 specifying the types of applications that may be
507 considered for grant funding; requiring the department
508 to appoint peer review panels to review the scientific
509 merit of grant applications and establish their
510 priority scores; requiring the council to consider the
511 priority scores in determining which proposals are
512 recommended for grant funding under the program;
513 requiring the council and peer review panels to
514 establish and follow certain guidelines when
515 performing their duties under the program; prohibiting
516 members of the council or peer review panels from
517 participating in discussions or decisions if there are
518 certain conflicts of interest; authorizing certain
519 appropriated funds to be carried forward under certain
520 circumstances; amending s. 383.14, F.S.; requiring the
521 department to create an evidence-based educational
522 pamphlet on the nutritional needs of preterm infants
523 for a specified purpose; requiring the department to
524 make the pamphlet available electronically to certain
525 hospitals by a specified date; specifying requirements
526 for the pamphlet; amending s. 395.4025, F.S.;
527 requiring that certain specialty licensed children’s
528 hospitals be deemed in compliance with specified
529 standards and be designated as pediatric trauma
530 centers if they meet specified criteria; amending s.
531 456.074, F.S.; requiring the department to issue an
532 emergency order suspending the license of a health
533 care practitioner arrested for committing or
534 attempting, soliciting, or conspiring to commit murder
535 in this state or another jurisdiction; amending s.
536 464.0156, F.S.; authorizing a registered nurse to
537 delegate the administration of certain controlled
538 substances to a home health aide for medically fragile
539 children under certain circumstances; amending s.
540 491.005, F.S.; revising licensure requirements for
541 marriage and family therapists; amending s. 1004.551,
542 F.S.; revising requirements for the micro-credential
543 component of specialized training provided by the
544 University of Florida Center for Autism and
545 Neurodevelopment; providing an effective date.